Morepen begins commercial supplies under ₹825 crore CDMO contract
after close1 source ↓written by the desknot a recommendation
- Contract Development
- ₹825 crore
- valued
- ₹50 crore
Morepen Laboratories has started commercial supplies under its ₹825 crore Contract Development and Manufacturing Organization (CDMO) agreement. The first dispatch, valued at ₹50 crore, marks a key transition to full-scale execution after successful validation and readiness phases. This milestone positions Morepen for long-term global manufacturing partnerships.
The commencement of supplies may enhance investor confidence and drive future growth prospects for the company.
Not investment advice. For informational purposes only.